We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
101
Oppenheimer Asset Management
New York
$7.31M -$456K -3,309 -6%
EAM
102
Eagle Asset Management
Florida
$7.18M -$39.7M -288,051 -85%
TPSF
103
Texas Permanent School Fund
Texas
$7.12M -$24.1K -175 -0.3%
KTC
104
Kistler-Tiffany Companies
Pennsylvania
$7.01M +$3.36M +24,388 +97%
AL
105
AJO LP
Pennsylvania
$6.94M +$6.74M +48,965 New
CEP
106
Chicago Equity Partners
Illinois
$6.74M +$6.55M +47,545 New
Man Group
107
Man Group
United Kingdom
$6.67M -$4.19M -30,454 -39%
Ohio Public Employees Retirement System (OPERS)
108
Ohio Public Employees Retirement System (OPERS)
Ohio
$6.65M +$1.08M +7,878 +20%
ASRS
109
Arizona State Retirement System
Arizona
$6.52M -$1.01M -7,370 -14%
Comerica Bank
110
Comerica Bank
Texas
$6.42M -$27.4K -199 -0.4%
AG
111
Aperio Group
California
$6.24M -$126K -916 -2%
GWI
112
Grace & White Inc
New York
$6.18M -$275K -2,000 -4%
LP
113
LMR Partners
United Kingdom
$6.18M +$3.05M +22,167 +104%
Canada Life
114
Canada Life
Manitoba, Canada
$6.18M -$15.3K -111 -0.3%
MIM
115
MetLife Investment Management
New Jersey
$6.08M -$88.4K -642 -1%
JG
116
Jefferies Group
New York
$6.07M +$3.71M +26,925 +169%
HFA
117
Hoover Financial Advisors
Pennsylvania
$5.79M -$107K -780 -2%
WBC
118
Westpac Banking Corp
Australia
$5.73M – – –
Thrivent Financial for Lutherans
119
Thrivent Financial for Lutherans
Minnesota
$5.71M -$11M -79,834 -66%
Stifel Financial
120
Stifel Financial
Missouri
$5.67M +$629K +4,568 +13%
RJA
121
Raymond James & Associates
Florida
$5.64M -$790K -5,739 -13%
MSA
122
Mason Street Advisors
Wisconsin
$5.49M -$67.7K -492 -1%
CCA
123
Conestoga Capital Advisors
Pennsylvania
$5.46M -$177K -1,285 -3%
GIM
124
Granahan Investment Management
Massachusetts
$5.39M -$1.34M -9,710 -20%
SB
125
Suntrust Banks
Georgia
$5.37M -$583K -4,234 -10%
3 4
5
6 7

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.